货号：UP382240925
| 产品信息 | |
| 产品名称： | DBPR108 |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 1186426-66-3 |
| 分子式： | C16H25FN4O2 |
| 分子量： | 324.39 |
| MDL NO： | - |
| 标准纯度： | 98+% (UP382240925) |
| 沸点： | - |
| 储存： | (UP382240925) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
PF-06380101
UP2841062041436391-86-4
MK-1775
UP260008146955365-80-7
Buclizine Dihydrochloride
UP263438853129-74-8
MC-MMAF
UP626166887863971-19-1
MF63
UP353911793892549-43-8
Acetylcysteine
UP747400921616-91-1
Etelcalcetide Hydrochloride
UP8052065091334237-71-6
WP1066
UP476294474857064-38-1
BMS-345541
UP194690505445430-58-0
Amiselimod hydrochloride
UP600185711942398-84-7
Wy-14643
UP54733767050892-23-4
XL019
UP683295852945755-56-6
Amlexanox
UP23527655368302-57-8
4-(trans-4-n-Pentylcyclohexyl)benzonitrile
UP61809428161204-01-1
Daun02
UP255025757290304-24-4
LY2835219
UP9188646851231930-82-7
Eltrombopag
UP167578331496775-61-2
Oclacitinib
UP3008053221640292-55-2
Maitansine
UP52823104535846-53-8
Podophyllotoxin
UP331982781518-28-5
TCS PIM-1 1
UP821396542491871-58-0
Daunorubicin
UP74928647420830-81-3
Oxytocin
UP67044909650-56-6
Ellagic acid
UP252462636476-66-4
ABT-751
UP759217016141430-65-1
PD1-PDL1 Inhibitor 3
UP5222094811629654-95-0
S3I-201
UP738281727501919-59-1
Factor XIa Inhibitor C18
UP8301542061329162-26-6
Parecoxib
UP865752409198470-84-7
MDL28170
UP30882867388191-84-8
G-5555
UP7759826371648863-90-4
KRP-203
UP996103472509088-69-1
Calcium-Sensing Receptor Antagonists I
UP254748097478963-79-0
Ixabepilone
UP738342624219989-84-1
GW501516
UP345740201317318-70-0
TAK-220
UP519118335333994-00-6
NMS-P715 analog
UP9185387301202055-34-2
Rosiglitazone maleate
UP230161406155141-29-0
Dimethylenastron
UP526581982863774-58-7
Bardoxolone
UP508110974218600-44-3
Raloxifene hydrochloride
UP40115764982640-04-8
Ticlopidine hydrochloride
UP89193225553885-35-1
Ciprofibrate
UP37874300552214-84-3
Cinacalcet hydrochloride
UP613007795364782-34-3
IKKε-IN-1
UP7372008501292310-49-6
Trametinib DMSO solvate
UP6788214981187431-43-1
CHLOROTRIANISENE
UP443642476569-57-3
ARRY-520 R-Enantiomer
UP133429052885060-08-2
Cinacalcet
UP578317275226256-56-0
NVP-BSK805
UP7001806891092499-93-8
Tofacitinib
UP532567784477600-75-2
1-Bromopyrrolidine-2,5-dione
UP997512001128-08-5
HMN-176
UP702620318173529-10-7
4'-Demethylepipodophyllotoxin
UP2370947666559-91-7
Kif15-IN-1
UP311108908672926-32-8
T0070907
UP897991509313516-66-4
Tofacitinib citrate
UP572148884540737-29-9
IVA-337
UP885360307927961-18-0
TPO agonist 1
UP2364729601033040-23-1
Cerdulatinib Hydrochloride
UP9968674041369761-01-2
ABT-263
UP761103440923564-51-6
Sitagliptin
UP694270381486460-32-6
SC514
UP213373567354812-17-2
Ozanimod
UP9634947741306760-87-1
APS-2-79 hydrochloride
UP6201759072002381-31-7
Pioglitazone hydrochloride
UP985561460112529-15-4
CFI-402257
UP3338386781610759-22-2
Cenicriviroc
UP674731788497223-25-3
GW9662
UP28984252122978-25-2
ARRY-520
UP213173265885060-09-3
KNK437
UP188849752218924-25-5
BAY 11-7085
UP512004021196309-76-9
WAY-262611
UP6224617681123231-07-1
AR-13324 mesylate
UP6578128841422144-42-0
AM095
UP6247851641345614-59-6
DBPR108
UP3822409251186426-66-3